Phio Pharmaceuticals Corp. (PHIO) › Operating IncomePhio Pharmaceuticals Corp. (PHIO) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2011: -$12.77M2012: -$12.97M2013: -$20.95M2014: -$8.83M2015: -$10.24M2016: -$9.02M2017: -$14.06M2018: -$7.36M2019: -$8.99M2020: -$8.79M2021: -$13.51M2022: -$11.46M2023: -$10.82M2024: -$7.39M2025: -$9.22M-$9.22M2011Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$9.22M-24.8%2024-$7.39M+31.8%2023-$10.82M+5.6%2022-$11.46M+15.2%2021-$13.51M-53.7%2020-$8.79M+2.2%2019-$8.99M-22.0%2018-$7.36M+47.6%2017-$14.06M-56.0%2016-$9.02M+11.9%2015-$10.24M-16.0%2014-$8.83M+57.9%2013-$20.95M-61.5%2012-$12.97M-1.6%2011-$12.77M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share